Tirzepatide Is Sufficient (Stay Put) If: You're close to your target weight: If tirzepatide has gotten you 8090% of the way to your goal, switching drugs mid-course introduces titration disruption and new side effects for a marginal numerical gain
Be patient: Sustainable weight loss takes time
State Medicaid Coverage of GLP-1s for Obesity Treatment (as of August 2024) KFF found that as of August 2024, 13 state Medicaid programs covered GLP-1s for obesity treatment within their fee-for-service programs
Our Products Form Cagrilintide COA Auxiliary Value in Regulating Gastrointestinal Dysfunction Gastrointestinal dysfunction is often associated with abnormal appetite and metabolic disorders, particularly in obese populations, where symptoms such as hyperphagia, uncontrolled eating, and postprandial bloating are common
Beyond insulation, fat cells are metabolically active
Citrus marinades on spicy chicken, hot salsa with lime, and spiced tomato-based soups can trigger acid reflux and nausea